Mode
Text Size
Log in / Sign up
N/A Completed N=55 Randomized Double-blind Other

A Clinical Comparison of Two Daily Disposable Soft Contact Lenses

Source: ClinicalTrials.gov NCT04005885 ↗
Enrolled (actual)
55
Serious AEs
0.0%
Results posted
Dec 2020
Primary outcomePrimary: Subjective Scores of Comfort at Insertion After 4 Weeks of Comfilcon A Use — 89.9 units on a scale

Summary

This double-masked, randomized, bilateral, crossover, direct refit study compared the clinical performance of two daily disposable contact lenses (somofilcon A and stenfilcon A) when fitted to existing wearers of comfilcon A monthly lenses.

Outcome Measures

OutcomeResultp-value
PRIMARY
Subjective Scores of Comfort at Insertion After 4 Weeks of Comfilcon A Use
89.9
PRIMARY
Subjective Scores of Comfort on Insertion
90.3; 90.4
SECONDARY
Subjective Scores on Overall Comfort After 4 Weeks of Comfilcon Use
83.7
SECONDARY
Subjective Scores on Overall Comfort
84.0; 85.7
SECONDARY
Subjective Scores on Comfort Before Removal After 4 Weeks of Comfilcon Use
73.1
SECONDARY
Subjective Scores on Comfort Before Removal
77.6; 79.3
SECONDARY
Number of Participants With Horizontal Lens Centration Grade
0; 0; 3; 1; 20; 30
SECONDARY
Number of Participants With Horizontal Lens Centration Grade After 4 Weeks of Comfilcon A Wear
0; 1; 32; 21; 0
SECONDARY
Number of Participants With Vertical Lens Centration Grade
0; 0; 10; 4; 22; 37
SECONDARY
Number of Participants With Vertical Lens Centration Grade After 4 Weeks of Comfilcon A Wear
0; 9; 38; 7; 0
SECONDARY
Number of Participants With Lens Corneal Coverage Grade
0; 0; 20; 3; 30; 43
SECONDARY
Number of Participants With Lens Corneal Coverage Grade After 4 Weeks of Comfilcon A Wear
0; 4; 43; 6; 1
SECONDARY
Number of Participants With Post-Blink Movement Grade
0; 0; 5; 5; 34; 28
SECONDARY
Number of Participants With Post-Blink Movement Grade After 4 Weeks of Comfilcon A Wear
0; 6; 38; 10; 0
SECONDARY
Investigator Lens Fit Acceptance
100; 100; 10; 21
SECONDARY
Investigator Lens Fit Acceptance for Comfilcon A After 4 Weeks of Use
98; 33

Eligibility Criteria

Inclusion Criteria

  • Subjects will only be eligible for the study if:
  • They are between 18 and 40 years of age (inclusive).
  • They understand their rights as a research subject and are willing and able to sign a Statement of Informed Consent.
  • They are willing and able to follow the protocol.
  • They are an existing soft reusable spherical contact lens wearer in both eyes.
  • They have a contact lens spherical prescription between -0.50 to -6.00D (inclusive) based on the ocular refraction.
  • They have a cylindrical correction of -0.875DC or less in each eye based on the ocular refraction
  • They own a wearable pair of spectacles and wear them on the day of the initial visit.
  • They have distance high contrast logMAR visual acuity of 0.2 or better in each eye with their habitual spectacles.
  • They agree not to participate in other clinical research for the duration of the study.

Exclusion Criteria

  • They have an ocular disorder which would normally contra-indicate contact lens wear.
  • They have a systemic disorder which would normally contra-indicate contact lens wear.
  • They are using any topical medication such as eye drops or ointment.
  • They are aphakic.
  • They have had corneal refractive surgery.
  • They have any corneal distortion resulting from previous hard or rigid lens wear or have keratoconus.
  • They are pregnant or breastfeeding.
  • They have any infectious disease which would, in the opinion of the investigator, contraindicate contact lens wear or pose a risk to study personnel; or they have any immunosuppressive disease (e.g. HIV), or a history of anaphylaxis or severe allergic reaction.
  • They have taken part in any other contact lens or care solution clinical trial or research, within two weeks prior to starting this study.
View full record on ClinicalTrials.gov →

Data sourced from ClinicalTrials.gov (NCT04005885). Outcome figures and adverse-event rates are extracted automatically from the registry's posted results and are provided for clinician reference, not as a substitute for the primary publication. Informational only — not medical advice.

Back to search